Ostuni, Universit Paris Cit, France Reviewed by Thiago Trovati Maciel, Institut National de la Sant et de la Recherche Mdicale (INSERM), France Loic Garcon, Centre Hospitalier Universitaire (CHU) d'Amiens, France Katell Peoch, Assistance Publique Hopitaux De Paris, France Updates Copyright 2024 Lin, Zheng, Chen, Xu and Huang
Side effects of CagriSema CagriSemas side effects follow the same pattern as other GLP-1 drugs
4.1.3 GLP-1 receptor agonists Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), traditionally recognized for glycemic regulation and weight management, exhibit renoprotective effects in DKD through multifactorial mechanisms
N-terminal modification of Nle